United States · FDA National Drug Code directory
alogliptin and metformin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-211_eb8e70d9-7ea0-4154-99b6-07e7ba15fe14
- Product NDC
- 45802-211
- Form
- TABLET, FILM COATED
- Composition / generic term
- alogliptin and metformin hydrochloride
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20160408
- Source listing expiry
- 20271231
Source-listed ingredients
- ALOGLIPTIN BENZOATE — 12.5 mg/1
- METFORMIN HYDROCHLORIDE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (45802-211-72) · 45802-211-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →